Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals

Brain Pathology

Volumn 22, Issue 1, 2012, Pages 67-78

  Kanazawa, Toshiro ^a,b   Adachi, Eijiro ^a,d   Orimo, Satoshi ^a,c   Nakamura, Ayako ^a   Mizusawa, Hidehiro ^b   Uchihara, Toshiki ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c The Mutualaid Association of Public School Teachers)   (Japan)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

synuclein; axon; collateral; pale neurite; Parkinson disease

Indexed keywords

ALPHA SYNUCLEIN; FLUOROCHROME; THIAZINE DERIVATIVE;

ARTICLE; EOSINOPHIL; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; LEWY BODY; NERVE FIBER; NEURITE; NEUROFILAMENT; PALE NEURITE; PARKINSON DISEASE; PROTEIN AGGREGATION;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; AXONS; BRAIN STEM; FEMALE; HUMANS; INCLUSION BODIES; LEWY BODIES; MALE; NEURITES; PARKINSON DISEASE; PROTEIN PRECURSORS;

EID: 83555166040     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00509.x     Document Type: Article

References (56)

1. Amino T, Orimo S, Itoh Y, Takahashi A, Uchihara T, Mizusawa H, (2005) Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol 15: 29-34. (Pubitemid 40224064)
2. Arima K, Uéda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H, Kawai M, (1998) Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808: 93-100. (Pubitemid 29003204)
3. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F, (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20: 415-455.
4. Braak H, Sandmann-Keil D, Gai WP, Braak E, (1999) Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett 265: 67-69. (Pubitemid 29210200)
5. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E, (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211. (Pubitemid 36007810)
6. Braak H, de Vos RAI, Bohl J, Del Tredici K, (2006) Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 396: 67-72. (Pubitemid 43233790)
7. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP, (1998) Semiconductor nanocrystals as fluorescent biological labels. Science 281: 2013-2016. (Pubitemid 28475485)
8. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ, (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546-4550. (Pubitemid 13077876)
9. Cajal SR, (1972) Histologie du Système Nerveux de L'homme et Des Vertébrés. p. 74. Consejo Superior de Investigaciones Científicas, Madrid: Madrid.
10. Chan WC, Nie S, (1998) Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281: 2016-2018. (Pubitemid 28475486)
11. Coleman MP, Perry VH, (2002) Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci 25: 532-537. (Pubitemid 35246324)
12. Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, et al, (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 115: 437-444.
13. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A, (2002) In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298: 1759-1762. (Pubitemid 35404113)
14. Duda JE, Giasson BI, Mabon ME, Lee VM-Y, Trojanowski JQ, (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body disease. Ann Neurol 52: 205-210. (Pubitemid 34810601)
15. Eslamboli A, Romero-Ramos M, Burger C, Bjorklund T, Muzyczka N, Mandel RJ, et al, (2007) Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain 130: 799-815. (Pubitemid 46410741)
16. Gai WP, Blessing WW, Blumbergs PC, (1995) Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain 118: 1447-1459. (Pubitemid 26011915)
17. Gai WP, Blumbergs PC, Blessing WW, (1996) Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease. Acta Neuropathol 91: 78-81.
18. Garcia- Reitböck P, Anichtchik O, Bellucci A, Iovino M, Ballini C, Fineberg E, et al, (2010) SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain 133: 2032-2044.
19. German DC, Dubach M, Askari S, Speciale SG, Bowden DM, (1988) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? Neuroscience 24: 161-174. (Pubitemid 18044250)
20. Gibb WRG, Scott T, Lees AJ, (1991) Neuronal inclusions of Parkinson's disease. Mov Disord 6: 2-11.
21. Gold PW, (2005) The neurobiology of stress and its relevance to psychotherapy. Clin Neurosci Res 4: 315-324. (Pubitemid 40754075)
22. Greenfield JG, Bosanquet FD, (1953) The brain-stem lesions in Parkinsonism. J Neurol Neurosurg Psychiatry 16: 213-226.
23. Hayashida K, Oyanagi S, Mizutani Y, Yokochi M, (1993) An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism. Acta Neuropathol 85: 445-448. (Pubitemid 23100936)
24. Herkenham M, Little MD, Bankiewicz K, Yang S-C, Markey SP, Johannessen JN, (1991) Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience 40: 133-158.
25. Imai H, Nakamura T, Endo K, Narabayashi H, (1988) Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP): behavior and histology. Brain Res 474: 327-332.
26. Jarvinen MK, Powley TL, (1999) Dorsal motor nucleus of the vagus neurons: a multivariate taxonomy. J Comp Neurol 403: 359-377. (Pubitemid 29006218)
27. Javitch JA, D'Amato RJ, Strittmatter SM, Snyder S, (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82: 2173-2177. (Pubitemid 15056491)
28. Kanazawa T, Uchihara T, Takahashi A, Nakamura A, Orimo S, Mizusawa H, (2008) Three-layered structure shared between Lewy bodies and Lewy neurites-three-dimensional reconstruction of triple-labeled sections. Brain Pathol 18: 415-422. (Pubitemid 351782850)
29. Kawai Y, Takagi H, Kumoi Y, Shiosaka S, Tohyama M, (1987) Nigrostriatal dopamine neurons receive substance P-ergic inputs in the substantia nigra: application of the immunoelectron microscopic mirror technique to fluorescent double-staining for transmitter-specific projections. Brain Res 401: 371-376. (Pubitemid 17221829)
30. Kireev I, Lakonishok M, Liu W, Joshi VN, Powell R, Belmont AS, (2008) In vivo immunogold labeling confirms large-scale chromatin folding motifs. Nat Methods 5: 311-313. (Pubitemid 351455157)
31. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW, (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 14: 504-506. (Pubitemid 351655212)
32. Kramer ML, Schulz-Schaeffer WJ, (2007) Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27: 1405-1410.
33. Krettek JE, Price JL, (1977) Projections from the amygdaloid complex to the cerebral cortex and thalamus in the rat and cat. J Comp Neurol 172: 687-722. (Pubitemid 8059157)
34. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y, (1988) Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol 75: 345-353. (Pubitemid 18070910)
35. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al, (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 14: 501-503. (Pubitemid 351655211)
36. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T, (2009) Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 29: 444-453.
37. Mesulam MM, Mufson EJ, Levey AI, Wainer BH, (1983) Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214: 170-197. (Pubitemid 13162962)
38. Mori F, Tanji K, Zhang H, Kakita A, Takahashi H, Wakabayashi K, (2008) α-synuclein pathology in the neostriatum in Parkinson's disease. Acta Neuropathol 115: 453-459.
39. Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H, (2008) Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 131: 642-650. (Pubitemid 351294710)
40. Parent M, Parent A, (2006) Relationship between axonal collateralization and neuronal degeneration in basal ganglia. J Neural Transm 70 (Suppl.): 85-88. (Pubitemid 44622183)
41. Resch JF, Scott Lehr G, Wischik CM, (1991) Design and synthesis of a potential affinity/cleaving reagent for beta-pleated sheet protein structures. Bioorganic Med Chem Lett 1: 519-522.
42. Roy S, Wolman L, (1969) Ultrastructural observations in parkinsonism. J Path 99: 39-43.
43. Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, et al, (2003) Accumulation of phosphorylated α-synuclein in aging human brain. J Neuropathol Exp Neurol 62: 644-654. (Pubitemid 36682637)
44. Sakamoto M, Uchihara T, Hayashi M, Nakamura A, Kikuchi E, Mizutani T, et al, (2002) Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red. Exp Neurol 177: 88-94. (Pubitemid 35356824)
45. Sandmann-Keil D, Braak H, Okochi M, Haass C, Braak E, (1999) Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique. Acta Neuropathol 98: 461-464. (Pubitemid 29476164)
46. Shoji M, Harigaya Y, Sasaki A, Uéda K, Ishiguro K, Matsubara E, et al, (2000) Accumulation of NACP/α-synuclein in Lewy body disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 68: 605-608. (Pubitemid 30248826)
47. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M, (1997) Alpha-synuclein in Lewy bodies. Nature 388: 839-840.
48. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M, (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95: 6469-6473. (Pubitemid 28249037)
49. Switzer RC, (2000) Application of silver degeneration stains for neurotoxicity testing. Toxicol Pathol 28: 70-83.
50. Szebenyi G, Callaway JL, Dent EW, Kalil K, (1998) Interstitial branches develop from active regions of the axon demarcated by the primary growth cone during pausing behaviors. J Neurosci 18: 7930-7940. (Pubitemid 28441031)
51. Uchihara T, (2007) Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol 113: 483-499. (Pubitemid 46672595)
52. Ungerstedt U, (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl 367: 1-48.
53. Wakabayashi K, Takahashi H, Ohama E, Ikuta F, (1990) Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79: 581-583. (Pubitemid 20170333)
54. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H, (1997) NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 239: 45-48. (Pubitemid 28055846)
55. Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, et al, (1998) Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 96: 445-452. (Pubitemid 28474751)
56. Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K, et al, (2005) Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45: 847-859. (Pubitemid 40395264)